MKS (NASDAQ:MKSI) Announces Quarterly Earnings Results

MKS (NASDAQ:MKSI) announced its quarterly earnings results on Tuesday. The scientific and technical instruments company reported $2.47 EPS for the quarter, missing analysts’ consensus estimates of $2.51 by ($0.04), Zacks reports. MKS had a net margin of 7.53% and a return on equity of 21.30%. The business had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $1.02 billion. During the same period in the previous year, the business posted $2.15 EPS. The firm’s revenue was up 10.5% on a year-over-year basis. MKS updated its Q1 2026 guidance to 1.720-2.280 EPS.

MKS Stock Down 4.8%

NASDAQ:MKSI opened at $250.36 on Thursday. The company has a debt-to-equity ratio of 1.64, a current ratio of 2.86 and a quick ratio of 1.81. MKS has a 1-year low of $54.84 and a 1-year high of $269.91. The company has a 50-day moving average of $201.14 and a 200 day moving average of $154.11. The firm has a market cap of $16.82 billion, a PE ratio of 57.29, a price-to-earnings-growth ratio of 1.83 and a beta of 1.95.

MKS Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 6th. Investors of record on Monday, February 23rd will be issued a $0.25 dividend. The ex-dividend date is Monday, February 23rd. This is an increase from MKS’s previous quarterly dividend of $0.22. This represents a $1.00 annualized dividend and a dividend yield of 0.4%. MKS’s dividend payout ratio is presently 21.36%.

Analyst Ratings Changes

MKSI has been the topic of several analyst reports. Deutsche Bank Aktiengesellschaft set a $305.00 price target on shares of MKS and gave the company a “buy” rating in a report on Thursday. Zacks Research upgraded MKS from a “hold” rating to a “strong-buy” rating in a report on Friday, January 23rd. Wells Fargo & Company upped their price objective on MKS from $175.00 to $210.00 and gave the company an “equal weight” rating in a research report on Thursday, January 22nd. KeyCorp reiterated an “overweight” rating and set a $310.00 target price on shares of MKS in a research report on Wednesday. Finally, Bank of America raised their price target on shares of MKS from $215.00 to $255.00 and gave the stock a “buy” rating in a research note on Thursday, January 22nd. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, MKS currently has an average rating of “Moderate Buy” and a consensus price target of $243.17.

Insider Buying and Selling

In other news, Director Elizabeth Mora sold 300 shares of the business’s stock in a transaction dated Tuesday, December 2nd. The shares were sold at an average price of $158.81, for a total value of $47,643.00. Following the completion of the sale, the director owned 18,963 shares in the company, valued at approximately $3,011,514.03. The trade was a 1.56% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.57% of the company’s stock.

Hedge Funds Weigh In On MKS

A number of large investors have recently added to or reduced their stakes in the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of MKS by 3.6% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 267,421 shares of the scientific and technical instruments company’s stock valued at $21,434,000 after buying an additional 9,170 shares in the last quarter. EverSource Wealth Advisors LLC lifted its position in MKS by 63.4% during the second quarter. EverSource Wealth Advisors LLC now owns 838 shares of the scientific and technical instruments company’s stock valued at $83,000 after acquiring an additional 325 shares during the last quarter. First Trust Advisors LP boosted its stake in MKS by 3,545.6% in the second quarter. First Trust Advisors LP now owns 141,267 shares of the scientific and technical instruments company’s stock valued at $14,036,000 after acquiring an additional 137,392 shares in the last quarter. Cerity Partners LLC purchased a new position in MKS in the second quarter worth $1,676,000. Finally, AXA S.A. grew its holdings in MKS by 22.8% in the second quarter. AXA S.A. now owns 29,253 shares of the scientific and technical instruments company’s stock worth $2,907,000 after purchasing an additional 5,430 shares during the last quarter. 99.79% of the stock is currently owned by institutional investors.

MKS Company Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.